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Cell surface-exposed and secreted proteins are attractive targets for 
vaccination against pathogenic Gram-positive bacteria. To obtain sufficient 
amounts of such antigens, efficient protein production platforms are needed. 
In this study a pipeline for the production and purification of surface-exposed 
and secreted antigens of the Gram-positive bacterial pathogen Staphylococcus 
aureus is presented. Cytoplasmic or extracellular production of S. aureus 
antigens was achieved using the Lactococcus lactis strain PA1001, which lacks 
the major extracellular protease HtrA and the autolysin AcmA to minimize 
proteolysis and cell lysis, respectively. For most tested S. aureus antigens, 
secretory production directed by the signal peptide of the major secreted 
protein Usp45 of L. lactis resulted in higher yields than intracellular production 
without a signal peptide. Additionally, secretory production of His-tagged 
antigens allowed their facile one-step purification from the growth medium by 
metal affinity chromatography. For three of the purified antigens biological 
activity was confirmed through enzyme activity assays. We furthermore show 
that the present pipeline can be used to produce staphylococcal antigens with 
an N-terminal AVI-tag for site-specific labeling with biotin, or a C-terminal cell 
wall-binding domain for cell surface display. We conclude that our L. lactis-
based pipeline allows the efficient production of S. aureus antigens and their 
subsequent purification in one step. 





For the production of vaccines against Gram-positive bacterial pathogens, the 
application of surface-exposed proteins has been shown to be very efficient (1). 
For the pathogen Staphylococcus aureus many studies to develop protective 
vaccines or antibodies based on the recognition of a surface protein have been 
undertaken (2). Using different proteomics approaches potentially invariant 
target proteins have been identified. These are either surface-exposed, 
secreted or both (3-5). Immuno-proteomics approaches have been applied to 
determine variations in the specific immune responses to these proteins in 
healthy and infected humans (6). This information pinpoints potential targets 
for immunotherapy against resistant S. aureus strains that now need to be 
validated through Enzyme-Linked Immuno Sorbent Assay, Luminex Flow 
Cytometry (7,8) protein arrays (9) or electrical protein array chips (10). All these 
techniques have in common that potential target proteins need to be 
overproduced and purified, which underscores the need for suitable expression 
systems. 
In most previous studies, protein targets have been (over-)produced in E. coli 
using the IPTG-inducible T7 promoter (9). Overexpression of heterologous 
proteins in E. coli can be very efficient, but problems such as low yields, the 
formation of inclusion bodies and protein degradation are often encountered 
(11,12). To avoid such problems, different solutions have been proposed, 
including the use of specific growth regimen to increase expression, the 
solubilization of inclusion bodies with urea or other denaturing compounds, 
and the use of specific strains with reduced proteolytic activity. Furthermore, E. 
coli produces lipopolysaccharide (LPS), generally referred as endotoxin, which 
needs to be removed before produced proteins can be used in clinical 
applications (12). 
Besides E. coli, several Gram-positive bacteria have been used for heterologous 
protein production, such as various Bacillus species (11,12) and Lactococcus 
lactis. The latter bacterium offers several advantages. L. lactis is a facultative 
anaerobe that is easy to culture. Importantly, compared to Bacillus species, L. 
lactis is barely proteolytic as it produces only one major extracellular protease, 
designated HtrA (13), and it secretes only one abundant protein known as 




heterologous proteins can be secreted from L. lactis in a folded and active state 
(15,16), which facilitates easy downstream processing. Lastly, the generally-
regarded as safe status, the availability of the complete genome sequence and 
a wealth of genetic tools for cloning and strain optimization make L. lactis 
ideally suited for the expression of heterologous proteins (17,18). This is 
exemplified by the efficient production and secretion of His-tagged proteins 
from Listeria monocytogenes in L. lactis (19). 
Different L. lactis expression systems have been developed of which the Nisin-
Controlled Expression (NICE) system has been shown to be most efficient 
(20,21). In this system, the lantibiotic Nisin is used as an inducer, which is 
sensed by the NisK histidine protein kinase located in the cell envelope (Fig. 1). 
NisK subsequently phosphorylates the response regulator NisR, which 
subsequently activates the transcription of (heterologous) genes that have 
been cloned downstream of the nisA promoter (14,21). Various vectors have 
been produced for use in the NICE system, some of which include the signal 




Figure 1. Schematic representation of nisin-induced expression and secretion of tagged S. 
aureus antigens by L. lactis PA1001. NisK is the sensor protein that phosphorylates (Pi) the 
response regulator NisR and activates the expression of the target gene. The expressed 
antigen is C-terminally fused to a His-tag (H) and can be N-terminally fused to an AVI-tag for 
enzymatic biotinylation. The antigen will be secreted into the growth medium via the 
general secretion (Sec) pathway when fused to the signal peptide (SP) of the Usp45 protein 
of L. lactis. Instead of the His-tag a protein anchor (PA) can be fused to the antigen for cell 
surface display. 
 
The proteolytic degradation of heterologous proteins can be a problem for 
stable protein production in L. lactis (22), but this can be overcome by deletion 
of the htrA gene (23). Another potential problem is autolysis of protein-







Lactococcus  lactis PA1001
ΔacmA – no autolysis





                            Efficient production of secreted staphylococcal antigens  
21 
 
medium and poses a challenge for the purification of secreted target proteins. 
Autolysis in L. lactis is mainly caused by the peptidoglycan hydrolase AcmA 
(24). Accordingly, deletion of the acmA gene was shown to result in a complete 
loss of autolysis even after 7 days of culturing (25). 
The aim of this study was to develop a pipeline for the expression and 
purification of tagged surface-exposed and secreted proteins from S. aureus. 
For this purpose, we used the S. aureus proteins Aly (SA2437), LytM (SA0265), 
Nuc (SA0746), SA0620, SA2097, and IsaA (SA2356) as reporters. These 
staphylococcal proteins are potentially relevant antigens, because in a previous 
study it was shown that they are invariably present in the exoproteomes of 25 
different clinical S. aureus isolates (3). Specifically, we compared the 
efficiencies of cytoplasmic and secretory production of these reporter proteins 
in acmA htrA double mutant L. lactis cells. In brief, the results show that such 
double mutant cells allow the efficient secretion of S. aureus proteins. 
 
Materials and Methods 
 
Bacterial strains and growth conditions 
Strains and plasmids are listed in Table 1. L. lactis strains were grown at 30ºC in 
M17 broth (Oxoid Limited, Hampshire, United Kingdom) with 0.5% glucose 
(w/v) (GM17). When necessary, the medium was supplemented with 
chloramphenicol (5 g/ml). The S. aureus strains N315 and Newman were 
grown overnight at 37oC as standing cultures using Tryptone Soy Broth (TSB, 
Oxoid Limited). 
 
General molecular biology 
Enzymes and buffers were from New England Biolabs (Ipswich, United 
Kingdom) and Fermentas (Landsmeer, The Netherlands). For cloning 
experiments T4 DNA ligase was used. Genomic DNA of S. aureus N315 was 
isolated with the Genelute bacterial genomic DNA kit (Sigma-Aldrich, 
Zwijndrecht, The Netherlands) according the manufacturer’s protocol with the 
following modifications. S. aureus cells were lysed using Lysostaphin (5 U/μl, 
Ambi Products, Lawrence, USA) in Gram-Positive Lysis Buffer for 20 min at 37 









, chloramphenicol resistance; Kan
r
, kanamycin resistance; PnisA, nisin-inducible promoter; usp45ss, signal 
sequence of usp45  
 
PCR reactions were performed with a DNA Engine Tetrad (MJ Research Inc., St. 
Bruno, Canada) or a Bio-rad C1000 Thermal cycler (Richmond, CA). Primers 
used in this study were obtained from Eurogentec (Maastricht, The 
Netherlands) (Table 2). The polymerases Taq (Life Technologies, Bleiswijk, The 
Netherlands), PWO (Roche, Woerden, The Netherlands), Phusion Hot Start 
(Thermo Fisher Scientific, Wilmington, Delaware USA) were used according to 
the manufacturer’s protocols. PCR products were purified using the High Pure 
PCR product purification kit from Roche. L. lactis cells were lysed with 
Lysozyme (4 mg/ml, Sigma-Aldrich) in kit solution A, 10 min at 55ºC, followed 
Strain or plasmids Relevant phenotype(s) or genotype(s) Source or reference 
Strains   
L. lactis NZ9700 Nisin producer [38] 
L. lactis NZ9000 MG1363 pepN::nisRK, allows nisin inducible expression [27] 
L. lactis PA1001 Derivative of NZ9000 lacking acmA and htrA [16] 
E. coli BL21DE3 Allows IPTG-inducible expression of T7-promoter Novagen 
S. aureus N315 MRSA [39] 
S. aureus Newman NCTC 8178 clinical isolate [40] 
Plasmids   
pNZ8048 Cm
r
, containing PnisA and a transcription terminator [20] 
pNG400 Cm
r
, pNZ8048 derivative with PnisA usp45ss followed by a MCS and a transcription 
terminator 
[16] 
pNG400::lytM::his6 pNG400 containing lytM with C-terminal his6  This study 
pNG400::nuc::his6 pNG400 containing nuc with C-terminal his6  This study 
pNG400::aly::his6 pNG400 containing aly with C-terminal his6  This study 
pNG400::sa0620::his6 pNG400 containing sa0620 with C-terminal his6  This study 
pNG400::sa2097::his6 pNG400 containing sa2097 with C-terminal his6  This study 
pNG400::avi::isaA::his6 pNG400 containing isaA with N-terminal AVI and C-terminal his6 This study 
pPA180 Cm
r
, pNZ8048 derivative containing PnisA and his6 [41] 
pPA180::lytM::his6 pPA180 containing lytM with C-terminal his6 [7] 
pPA180::nuc::his6 pPA180 containing nuc with C-terminal his6 [7] 
pPA180::aly::his6 pPA180 containing aly with C-terminal his6 [7] 
pPA180::sa0620::his6 pPA180 containing sa0620 with C-terminal his6 This study 
pPA180::sa2097::his6 pPA180 containing sa2097 with C-terminal his6 This study 
pPA224 pNZ8048 derivative with PnisA, usp45ss and 3 LysM repeats of acmA (PA-domain)  [42]  
pPA224::his6 pPA224 containing N-terminal his6 fused to PA-domain This study 
pPA224::lytM pPA224 containing lytM with C-terminal PA-domain This study 
pPA224::nuc pPA224 containing nuc with C-terminal PA-domain This study 
pPA224::aly pPA224 containing aly with C-terminal PA-domain This study 
pPA224::sa0620 pPA224 containing sa0620 with C-terminal PA-domain This study 
pPA224::sa2097 pPA224 containing sa2097 with C-terminal PA-domain This study 
pET24d::isaA::his6 Kan
r
, pET24d containing isaA with C-terminal his6  Laboratory collection 
pET24d::avi::isaA::his6 Kan
r
, pET24d containing isaA with N-terminal avi and with C-terminal his6  This study 
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by addition of the lysis buffer provided with the Invisorb Spin Plasmid Mini Two 
kit (Invitek GmbH, Berlin, Germany). Nucleotide sequence analyses were 
performed by Eurofins DNA (Ebersberg, Germany). Electrotransformation of L. 
lactis was performed using a Gene pulser (Bio-Rad Laboratories) as described 
by (26). 
 
Table 2: Primers used in this study 












0620.fw CCCGTCTCCCATGGGATCTACACAACATACAGTACAATC  BsmBI
a
 































































NucHis.rev GATGTCGGTCTCGAATTCCTTGACCTGAATCAGCGTTGTCTTCGC BsaIc 
LytMHis.fw CACTCAGGTCTCCCATGGGAGCAGAAACGACAAACACCCAACAA BsaIb 
LytMHis.rev ATGTCGGTCTCGAATTCCTCTACTTTGCAAGTATGACGTTGGGTC BsaIc 
a, BsmBI site underlined, resulting in 5’ NcoI overhang  in italic; bBsaI site underlined, resulting in 5’NcoI 
overhang in italic; c, BsaI sit underlined, resulting in 5’EcoRI overhang in italic 
 
Construction of expression plasmids 
For construction of pPA224::his primer His_PA.fw was used in combination 
with P_His_PA.rev, using pPA224 as template. The resulting PCR product was 
ligated and transferred to L. lactis PA1001. 
For extracellular production of Aly, LytM, Nuc, SA0620 and SA2097 fused to the 
PA cell wall anchor (i.e. three tandem LysM repeats of L. lactis AcmA), the 
respective genes where amplified using primer combinations 
Aly224.fw/Aly224.rev, LytM224.fw/LytM224.rev, Nuc224.fw/Nuc224.rev, 
SA0620224.fw/SA0620224.rev and SA2097224.fw/SA2097224.rev. The 
resulting PCR products and receiving plasmid pPA224 were cut with the 
restriction enzymes BsaI and BbsI. After ligation, the resulting vectors were 
used to transform L. lactis PA1001. 
C-terminally His-tagged fusions for intracellular production of Aly, LytM, Nuc, 
SA0620 and SA2097 were PCR-amplified with primer combinations 
AlyHis.fw/AlyHis.rev, LytMHis.fw/LytMHis.rev, NucHis.fw/NucHis.rev, 
0620His.fw/0620His.rev and 2097His.fw/2097His.rev using chromosomal DNA 
of S. aureus N315 as the template. Amplified DNA fragments were cleaved with 
BsaI resulting in NcoI and EcoRI overhangs. The receiving plasmid pPA180 was 
cleaved with NcoI and EcoRI. After ligation, the resulting plasmids were used to 
transform L. lactis PA1001. 
A C-terminal His-tag fusion of Aly for extracellular production was constructed 
by cleaving pPA180::aly::his6 with NcoI and HindIII and ligation into pNG400 cut 
                            Efficient production of secreted staphylococcal antigens  
25 
 
with the same enzymes, resulting in pNG400::aly::his6. For construction of 
pNG400::lytM::his6 the same strategy was used. The construction for 
extracellular production of Nuc-His6 was made by digestion of 
pPA180::nuc::his6 with XhoI and NcoI and ligation into pNG400 cut with the 
same enzymes. For construction of C-terminally His-tagged fusions of S. aureus 
SA2097 and SA0620, PCR reactions were performed on pPA180::sa2097::his6 
and pPA180::sa0620::his6 using primers 2097.fw and 0620.fw, respectively in 
combination with pPA180.rev. The amplified DNA fragment was cut with HindIII 
and BsmBI and ligated into pNG400 cleaved with NcoI and HindIII. 
For N-terminal fusion of avi to isaA::his in pET24d::isaA::his6, primers Avi-tag.fw 
and Avi-tag.rev were diluted in ligation buffer (Fermentas) and heated to 90ºC 
for 15 min. The temperature was decreased slowly to room temperature 
resulting in annealing of the primers generating NcoI overhangs. 
pET24::isaA::his6 cut with NcoI was ligated with avi resulting in removal of the 
NcoI site, and the respective ligation mixture was used to transform E. coli 
BL21DE3. Subsequently the avi::isaA::his6 fusion was cloned into pNG400 using 
primers AVIIsaA.fw and AVIIsaA.rev with pET24::avi::isaA::his6 as a template. 
The resulting PCR product was cut with BsmBI and HindIII and ligated into 
pNG400 cut with NcoI and HindIII. 
 
Protein production, detection, isolation and quantification 
Cultures of L. lactis were diluted 1:20 in fresh GM17 medium. Induction of PnisA 
was performed at OD600 ~0.5 for 16 hours by adding the culture supernatant 
(1:1000) from an overnight culture of the nisin-producing strain L. lactis 
NZ9700 as described (16). Cells and growth medium were separated by 
centrifugation. Proteins in the growth medium fraction were precipitated with 
10% trichloroacetic acid (TCA; 10% w/v final concentration) and dissolved in 
LDS buffer (Lithium Dodecyl Sulfate, Life Technologies). Cells were resuspended 
in LDS buffer and disrupted by bead-beating with 0.1 um glass beads (Biospec 
Products, Bartlesville, USA) using a Precellys24 bead beater (Bertin 
Technologies, Montigny-le-Bretonneux, France). Protein samples were 
incubated at 95ºC for 10 min, separated by LDS-PAGE using precast 10% 
NuPage gels (Invitrogen) and stained with SimplyBlueTM SafeStain (Life 
Technologies). For Western Blotting analyses, proteins separated by LDS-PAGE 




Dassel, Germany). Immunodetection was performed using anti His-tag 
antibodies (Life Technologies), rabbit polyclonal antibodies raised against PA 
(Eurogentec), or polyclonal antibodies against AVI (Genscript, Piscataway, USA). 
Bound antibodies were visualized using fluorescently labeled secondary 
antibodies (IRDye 800 CW from LiCor Biosciences, Nebraska, USA). Membranes 
were scanned for fluorescence at 800 nm using the Odyssey Infrared Imaging 
System (LiCor Biosciences). 
For protein isolation cells were disrupted by bead-beating in binding buffer (20 
mM NaPi, pH7.4, 0.5 M NaCl2, 50 mM Immidazole). Extracellular production of 
proteins were precipitated with TCA. Cleared lysate or supernatant fractions 
were applied to Ni-Sepharose Fast Flow (GE Healthcare Life Sciences, Diegem, 
Belgium) and washed with 3 column volumes of binding buffer. His-tagged 
proteins were eluted with 3 column volumes of binding buffer containing 500 
mM imidazole. Fractions containing the purified His-tagged proteins were 
pooled and dialyzed against PBS. 
Protein concentrations were determined with the DC Protein Assay (BioRad) 
using Bovine Serum Albumin (Sigma Aldrich) as a standard or with the 
Nanodrop ND-1000 (Thermo Fisher Scientific) using calculated extinction 
coefficients (http://www.biomol.net/en/tools/proteinextinction.htm). 
 
Protein activity assays 
Peptidoglycan hydrolase activity was detected by a zymogram staining as 
described previously (25). Nuclease activity was tested by mixing ~50 ng of 
Nuc-His6 or 200 ng DNAse (Roche) with 25 μg of chromosomal DNA of S. aureus 
in buffer L (10 mM Tris-HCl, 10 mM MgCl2, 1 mM dithioerythritol, final 
concentration) for restriction endonucleases (Roche). Mixtures were incubated 
for 5 min at room temperature. Enzyme activity was stopped by adding DNA-
loading buffer and DNA degradation was monitored using 1.0% agarose gels. 
Peptidoglycan-degrading activity of LytM was determined by measuring the 
reduction in OD600 after 90 min incubation of S. aureus Newman cells (diluted 
to an OD600 of 0.5 in PBS) with 50 μg of purified LytM at 37°C. S. aureus cells 
used were grown in TSB and washed with and dissolved in PBS. As a control, 
the cells were incubated with PBS. 
 
 




For biotinylation of AVI-IsaA-His6 produced in L. lactis, medium fractions of 
overnight induced cell cultures were 10-fold concentrated using TCA 
precipitation. As a negative control His6-FtsL was used. The precipitated protein 
pellets were biotinylated at 30°C for 1 hour using BirA500 (Avidity, Aurora, 
USA) according to the manufacturer’s instructions. Biotinylation was analyzed 
using LDS-PAGE combined with Western Blotting. After blocking the 
nitrocellulose membrane in 5% BSA in TBS (50 mM Tris, 150 mM NaCl, pH 8), 
the biotinylated proteins were targeted with Streptavidin conjugated to 
Alkaline Phosphatase (AP; Sigma-Aldrich) in 1:5,000 dilution. Streptavidin 
binding was visualized using a 50x diluted NBT/BCIP (nitro-blue tetrazolium 
chloride/5-bromo-4-chloro-3'-indolyphosphate p-toluidine salt) stock solution 
(Roche) in AP-buffer (100 mM Tris-HCl, pH 9.5, 100 mM NaCl, 50 mM MgCl2). 




Reduced lysis and protein degradation using an autolysis and proteolysis 
deficient strain of L. lactis as a production host. 
As a first approach to determine whether an acmA htrA double mutation can 
be beneficial for the production of S. aureus antigens, the His-tagged fusion 
protein LytM-His6 was used. This reporter protein was furthermore fused to the 
signal peptide of Usp45 for secretion into the growth medium by expression 
from pNG400. As shown in Figure 2, the LytM-His6 fusion protein was 
effectively produced and secreted both by L. lactis NZ9000 (acmA- and htrA-
proficient) and L. lactis PA1001 (acmA- and htrA-deficient). Notably, about 50% 
of the fusion protein was retained in the cell probably due to cell wall retention 
by the cell wall-binding of LytM (29). Western blotting analysis of the cell and 
growth medium fractions showed that the LytM-His6 fusion protein is subject 
to proteolytic degradation in strain NZ9000 as bands with a higher 
electrophoretic mobility than that of the full-size fusion protein were detected 
(Fig. 2, lanes marked N). No degradation of the LytM-His6 protein was observed 
in the cell and growth medium fractions of L. lactis PA1001 (Fig. 2, lanes 
marked P). Furthermore, comparison of the growth medium fractions of 




medium of strain PA1001, suggesting that this strain is less prone to autolysis 
(Fig. 2A). Taken together, these results show that the L. lactis PA1001 strain is 
preferable over the NZ9000 strain for the secretory production of S. aureus 
antigens, like LytM-His6. Therefore this strain was also selected for the 
expression of the other His-tagged S. aureus proteins used in this study. 
 
  
Figure 2. Reduced degradation of LytM-His6 and loss of cell lysis upon expression in L. lactis 
PA1001. Cell and growth medium fractions of L. lactis NZ9000 (N) or L. lactis PA1001 (P) 
producing LytM-His6 were analyzed by LDS-PAGE. Gels were either stained with Simply blue 
safe stain (a) or used for Western blotting (b) with anti-Histidine antibodies. Grey arrow 
heads indicate mature LytM-His6, black arrow heads indicate LytM-His6 dimers, white arrow 
heads indicate degradation products detectable after secretion by strain NZ9000. The 
molecular weight of marker proteins is indicated (in kDa). 
  
Efficient intracellular or secretory production of His-tagged staphylococcal 
antigens in L. lactis. 
To further explore the potential of L. lactis PA1001 for the production of S. 
aureus antigens, the genes for the Aly, LytM, Nuc, SA0620, SA2097 and IsaA 
proteins were cloned in the NICE system using plasmid pPA180 for intracellular 
production, or plasmid pNG400 for secretory production driven by the Usp45 
signal peptide. Notably, for cloning in either vector, the authentic signal 
sequences of the different S. aureus proteins were removed. Furthermore, the 
genes were cloned in such a way that the expressed S. aureus antigens were 
provided with a C-terminal His-tag. As shown by LDS-PAGE and subsequent 
Simply Blue staining (Fig. 3A) or Western Blotting with antibodies against the 
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His-tag (Fig. 3B), the intracellularly produced His6-tagged fusion proteins (lanes 
marked ‘Cytoplasmic’) were exclusively detectable in the cell lysates. Only in 
case of the SA0620-His6 fusion, a degradation product of ~17 kDa was detected. 
Furthermore, expression of SA2097-His6 was found to be relatively low 
compared to the other S. aureus antigens. 
When the His-tagged S. aureus proteins were fused to the signal peptide of 
Usp45, all His-tagged S. aureus proteins were secreted into the growth medium 
except for SA0620-His6 (Fig. 3, lanes marked ‘+ssUsp45’). In addition, 
substantial amounts of these proteins were detectable in the cell lysates. A 
similar degradation product of the SA0620-His6 fusion protein as observed 
upon intracellular production was observed also upon secretory production. 
Western analysis using anti-His antibodies showed that the full size SA0620-
His6 is present in the cell lysate but not in the supernatant. Relatively high 
levels of production and secretion were observed for LytM-His6 and Nuc-His6, 
while relatively inefficient secretion was observed for Aly-His6. The SA2097-His6 
fusion protein was produced at relatively low levels but its secretion was 
efficient (Fig. 3). Interestingly, for all secreted fusion proteins we detected 
slowly migrating bands, which possibly represent multimeric forms (Fig. 3B). 
Altogether, these results show that L. lactis can be used for intracellular and 
secretory production of antigens that are naturally secreted by S. aureus. 
Importantly, secretory production leads to higher yields and is therefore the 
preferred option to produce the investigated S. aureus antigens. 
 
Efficient production and secretion of staphylococcal antigens tagged with a 
cell wall anchor in L. lactis. 
In a next series of experiments the Aly, LytM, Nuc, SA0620, SA2097 and IsaA 
proteins were cloned in the NICE system using pPA224. By doing so, these 
proteins were fused to the PA cell wall anchor sequence, which allows their cell 
surface display in L. lactis (16,30). Upon nisin induction, clear production and 
secretion of Aly-PA, LytM-PA and Nuc-PA was observed upon LDS-PAGE and 
Simply Blue staining of the separated proteins (Fig. 3A). A somewhat lower 
production and secretion level was observed for SA2097-PA. In contrast, the 
full-size SA0620-PA fusion protein of 51 kDa remained undetected in the 










Figure 3. Analysis of cytoplasmic and secreted production of His-tagged or PA-tagged S. 
aureus antigens by L. lactis PA1001. (a) Cells and growth medium fractions of L. lactis 
PA1001 expressing cytoplasmic (-ssUsp45) or secreted (+ssUsp45) His-tagged or PA-tagged 
staphylococcal antigens were analyzed by LDS-PAGE. Gels were stained with Simply blue safe 
stain. An additional band of approximately 37 kDa is indicated by a star. Usp45 in the growth 
medium fraction is marked. Control, samples of an uninduced L. lactis PA1001 strain. The 
molecular weight of marker proteins is indicated (in kDa). (b) Cells and growth medium 
fractions of L. lactis PA1001 expressing His-tagged cytoplasmic (-ssUsp45) or secreted 
(+ssUsp45) staphylococcal antigens were analyzed by Western Blotting using anti-Histidine 
antibodies. Grey arrow heads indicate the produced fusion proteins, black arrow heads 
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Instead, a specific degradation product of around 37 kDa was observed upon 
LDS-PAGE. Western Blotting analysis using specific anti-PA antibodies showed 
the presence of multiple degradation products for this fusion protein (Fig. 4), 
indicating that it is prone to proteolysis even in the PA1001 strain. It should be 
noted that in all supernatant fractions the Usp45 protein (~50 kDa) and an 
additional band of approximately 37 kDa (marked with a star in Fig. 3A) were 
detectable. No signal was obtained for proteins of this size in the Western 
analysis using antibodies raised against the PA anchor (Fig. 4), indicating that 
the 37 kDa band does not contain the PA domain or fragments thereof. 
 
 
Figure 4. Western analysis of expressed and secreted PA-fusions of staphylococcal proteins 
produced by L. lactis PA1001. Cell lysates and culture supernatant samples of L. lactis 
PA1001 expressing the PA-fusions shown in Figure 3 were analyzed by Western 
Blotting using anti-PA antibodies. Grey arrow heads indicate the produced fusion proteins. 
The molecular weights of marker proteins are indicated (in kDa). 
 
Comparison of the cell lysates and the supernatant fractions of the strains 




protein is located in the respective cell lysate (Fig. 4). This is most likely due to 
the presence of the PA-domain as a PA-His6-tag fusion composed of only the PA 
anchor and a His-tag showed a similar distribution in the growth medium and 
cell fractions upon expression in the PA1001 strain (Fig. 5). Moreover, the cell-
associated PA-His6 fusion could be stripped from the cells by boiling the 
bacterial cell pellet in LDS loading buffer, which indicates that this fusion was 
associated to the cell wall. Although more proteins are released from the cells 
upon boiling in LDS loading buffer, the PA-His6 fusion is the most abundantly 
released protein, indicating that its release is not due to cell lysis. Together, 
these observations indicate that the S. aureus proteins fused to the PA anchor 
are translocated across the cell membrane. Subsequently, about 50% of each 
produced PA-fusion protein is retained in the cell wall while the other 50% is 
released into the growth medium. 
 
 
Figure 5. Secretion and cell wall binding of His6-PA produced by L. lactis PA1001. LDS-PAGE 
analysis of His6-PA produced by L. lactis PA1001 and subsequent protein detection with 
Simply Blue staining. Lane 1, TCA-precipitated supernatant of L. lactis PA1001 producing 
His6-PA. Lanes 2 and 3, cell lysates of PA1001 producing His6-PA before (lane 2) or after (lane 
3) stripping the cells with LDS buffer. Lane 4, Proteins released from the cell wall upon 
stripping with LDS buffer. 
 
Secretion of soluble AVI-IsaA-His6 by L. lactis. 
To be able to label staphylococcal antigens at a specific site, for example with a 
fluorescent dye, the possibility to use an AVI-tag was explored by fusing this tag 
to the N-terminus of the IsaA-His6 protein. The AVI-tag is a unique 15 amino 
acid peptide (GLNDIFEAQKIEWHE) to which biotin can be coupled by the biotin 
ligase (BirA) from E. coli. As shown by LDS-PAGE the AVI-IsaA-His6 fusion 
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protein was efficiently secreted from L. lactis PA1001 (Fig. 6A). Furthermore, 
the secreted protein contained both the AVI-tag and the His-tag as verified by 
Western Blotting using specific antibodies (Fig. 6A). Next, the AVI-IsaA-His6 
protein produced by L. lacis was tested for biotinylation (Fig. 6B). To this end, 
cells and growth medium were separated by centrifugation, and the growth 
medium fraction was TCA precipitated. Next, the AVI-IsaA-His6 protein was 
resuspended in biotinylation buffer containing biotin and incubated with BirA. 




Figure 6. Extracellular production and biotinylation of AVI-IsaA-His6 in L. lactis PA1001. 
(a) For the detection of extracellularly produced AVI-IsaA-His6 by L. lactis PA1001, cells (C) 
and TCA-precipitated growth medium fractions (S) of non-induced (-) and induced (+) cell 
cultures were separated by LDS-PAGE. Subsequently, the gel was stained with Simply Blue 
(SB), or used for Western Blotting with Anti-Histidine or Anti-AVI antibodies. The molecular 
weight of marker proteins is indicated. (b) TCA precipitations of AVI-IsaA-His6 (IsaA) and His6-
FtsL (FtsL) were incubated without (-) or with (+) BirA. Proteins were separated on an LDS-
PAGE gel and blotted on nitrocellulose membranes. Biotinylation was analyzed by binding of 
Streptavidin-AP and visualized using NBT/BCIP. As a control Western Blotting was performed 




As shown by alkaline phosphatase activity assays, this procedure resulted in 
efficient detection of the biotinylated AVI-IsaA-His6 (Fig. 6B). In contrast, the 
His-tagged control protein FtsL, which lacked the AVI-tag, was not detectable 
with the streptavidin-alkaline phosphatase conjugate. A background signal of 
approximately 25 kDa was detected in all TCA precipitated medium fractions, 
both in the BirA treated and untreated samples indicating that this signal is not 
obtained due to biotinylation of a naturally secreted lactococcal protein. 
Together, these findings show that even S. aureus proteins with multiple tags 
can be efficiently secreted using L. lactis. 
 
Facile protein purification from cytoplasmic or supernatant fractions of L. 
lactis. 
To assess whether the intracellularly or secreted S. aureus antigens could be 
readily purified from overproducing L. lactis cells grown in 500 ml of GM17 
broth, we performed metal affinity chromatography. As shown in Figure 7, the 
overproduced LytM-His6 was successfully isolated from either disrupted cells or 




Figure 7. Purification of LytM-His6 from L. lactis cells or the growth medium.  
Intracellularly produced LytM-His6 protein was isolated from cells (C), and extracellularly 
produced LytM-His6 from the growth medium (M) as detailed in the Materials and Methods. 
The flow through (F) fractions, wash and elution fractions were analyzed by LDS-PAGE. The 
position of the LytM-His6 protein is indicated by the arrow. 
 
Subsequent quantification of the amounts of purified protein showed that 
about 4-fold more LytM-His6 was purified from the growth medium than from 
LytM
C  F|   wash |  elution M F|  elution
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the cells (Table 3). Similar amounts of Nuc-His6 were obtained from the growth 
medium of overproducing cells, but in this case the amount of protein purified 
from the cells was about 1.5-fold higher than observed for LytM-His6. 
Compared to LytM-His6 and Nuc-His6, significantly lower amounts of Aly-His6, 
SA0620-His6 and SA2097-His6 were isolated from the growth medium fractions 
(Table 3). 
 
Table 3 Overproduction of heterologous proteins 
 
a SA number based on NCBI annotations of genome S. aureus strain N315; b the number and 
location (both indicated between brackets) of specific domains according the Pfam database 
(http://pfam.sanger.ac.uk/search); c signal peptide (SP) according to SignalP 3.0 
(http://www.cbs.dtu.dk/services/ SignalP/); d surface location of protein according to (1) (4); 
(2) (43); (3) (33); (4) (44); (5) (45); (6) (34,); (7) (46); e Isoelectric point and molecular weight (f) of 
the secreted protein including the His-tag or PA-fusion; g amount of protein (mg) isolated 
from 500 ml of culture; nd not determined. 
 
Lastly, we investigated whether intracellularly or extracellularly produced and 
subsequently purified proteins were active. As shown in Fig. 8, the Nuc-His6 
purified from cells or the growth medium efficiently degraded chromosomal 
DNA of S. aureus N315. The peptidoglycan-degrading activity of LytM-His6 
purified from cells or the growth medium was tested by incubation with cells of 
S. aureus Newman. After 90 min incubation at 37°C, a 14.0% reduction of the 




from L. lactis cells. Similarly, a reduction of 16.4% in OD600 was observed when 
LytM-His6 purified from the L. lactis medium was used. In contrast, the OD600 
decreased merely by 6.2% in the absence of LytM-His6. Activity of Aly-His6 
purified from L. lactis growth medium was enzymatically active, as visualized 
with zymograms using M. lysodeikticus as a substrate (Results not shown). 
From these results, we conclude that biological active His-tagged 
staphylococcal proteins can be efficiently isolated from overproducing L. lactis 
cells or the L. lactis growth medium using affinity chromatography. Notably, 
purification from the growth medium involves only a one-step procedure 
where the growth medium is directly used for metal affinity purification. 
 
 
Figure 8. Detection of Nuclease activity of purified Nuc-His6. Chromosomal DNA of S. aureus 
N315 (1) was incubated for 5 min with commercial DNAse (2), Nuc-His6 isolated from the 





The present study was aimed at developing a pipeline for the expression and 
purification of tagged surface-exposed and secreted antigens from S. aureus. 
For this purpose, the L. lactis strain PA1001 was selected as an expression host 
that lacks both the major HtrA protease and the autolysin AcmA. The results 
show that all six tested S. aureus antigens were produced in L. lactis, either 
intracellularly or extracellularly, albeit to different levels. When provided with a 
C-terminal His-tag these antigens could be readily isolated using metal affinity 
M    1     2     3    4
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chromatography and, where tested, the purified proteins had retained their 
biological activity. Furthermore, our results show that S. aureus antigens can be 
expressed effectively in L. lactis with a PA-tag for cell surface display, or an AVI-
tag for labeling with biotin. 
In a previous study it was shown that the HtrA protease can interfere with 
efficient protein production in L. lactis (23). This view is supported by our 
observation that the S. aureus LytM-His6 protein was subject to proteolysis in 
an HtrA-proficient strain. Nevertheless, the htrA mutation did not completely 
preclude cleavage of produced S. aureus antigens. This degradation was 
particularly evident for SA0620-His6, but also in the case of Nuc-His6 a minor 
degradation product was detectable by Western Blotting. At present, we do 
not know which protease is responsible for the observed cleavage, but it could 
be the cytoplasmic ClpP protease since ClpP was previously implicated in Nuc 
degradation (31). 
Five of the investigated S. aureus antigens were expressed either with or 
without the signal peptide of the secreted L. lactis protein Usp45. Four of these 
five antigens, were efficiently secreted due to the presence of the Usp45 signal 
peptide. Only the secretion of SA0620-His6 remained undetectable. In contrast, 
all five investigated antigens were produced intracellularly in absence of the 
Usp45 signal peptide. This included SA0620-His6, which could subsequently be 
purified from the cells. The latter observation shows that for some S. aureus 
antigens, intracellular production may be an option if secretion cannot be 
achieved. 
The S. aureus antigens Aly-His6, LytM-His6, Nuc-His6 and SA2097-His6 were 
successfully secreted using the Usp45 signal peptide. Nevertheless, substantial 
amounts of each of these proteins were retained in the respective producing 
cells. For Aly-His6 and SA2097-His6, this relates most likely to the presence of 
domains for non-covalent cell wall-binding. Specifically, the Aly and SA2097 
proteins have so-called cysteine histidine dependent amidohydrolase/ 
peptidase (CHAP) cell wall-binding domains (5,32), which may be responsible 
for cell retention. Notably, a C-terminal CHAP domain is also present in SA0620 
and, moreover, this protein has two N-terminal LysM domains that also 
facilitate non-covalent cell wall-binding (5) . It is thus very well conceivable that 
this protein is completely retained in the L. lactis cell wall by its CHAP and LysM 




LytM and Nuc protein have a dual localization in S. aureus, being present both 
in the cell wall and the growth medium (33,34). It is therefore not surprising 
that this is also the case when these proteins are exported from the L. lactis 
cytoplasm using the Usp45 signal peptide. Yet, the precise cell wall-binding 
mechanism(s) of LytM and Nuc are currently enigmatic. 
Importantly, the extracellular production of S. aureus antigens in L. lactis 
simplifies their isolation as exemplified with Aly-His6, LytM-His6, Nuc-His6 and 
SA2097-His6, which were all purified in one step from culture supernatants 
using metal affinity chromatography. For Aly-His6, LytM-His6 and Nuc-His6, the 
yields were clearly higher when these proteins were purified from the growth 
medium than from the cells. Only in the case of SA2097-His6, similar amounts 
of protein were isolated from cells or the growth medium but, clearly, the one-
step purification from the growth medium was easier. 
In conclusion, our present observations show that the non-lysing and 
proteolytically reduced L. lactis strain PA1001 is an excellent expression host 
for surface-bound and secreted antigens of S. aureus. While all tested antigens 
were produced and purified, for some antigens like SA0620 higher yields may 
be desirable. As was shown in previous studies this can potentially be achieved 
through the deletion of the gene for the major cytoplasmic protease ClpP (31), 
or deletion of the ybdD gene for a protein of unknown function, which was 
recently shown to enhance Nuc secretion by L. lactis (35). Alternatively, the 
secretion properties of L. lactis can potentially be enhanced by heterologous 
expression of the B. subtilis SecDF protein, a non-essential protein 
translocation machinery component that is absent from L. lactis, as was shown 
by Nouaille et al. (36).Lastly, it could be an option to improve the secretion of 
problematic antigens by mutating the signal sequence of Usp45, as was shown 
by Ng. and Sarkar [17], or by the use of alternative tags. Whether this will lead 
to gram per liter protein yields as obtained, for example, with Bacillus species is 
questionable. However, we believe that L. lactis will be suitable for producing 
sufficient amounts of protein for pilot studies and, if needed, bacilli could 
eventually be used for bulk production. However, this would then require 
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